Aims-To assess the performance of 2-sucrose-phosphate based transport medium (2-SP) for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae by an automated commercial polymerase chain reaction (PCR) and ligase chain reaction (LCR) compared to centrifugation culture on McCoy cells for C trachomatis. Second, to compare both amplification systems for initial diagnostic testing of a low prevalence population for sexually transmitted diseases. Methods-Four hundred and eighty one consecutive urogenital and conjunctival specimens were examined. All tests were performed on the same specimen collected with a dacron swab and transported in 2-SP medium. Samples that were positive by culture or by both PCR and LCR were considered to be true positives. Results-The prevalences of C trachomatis and of N gonorrhoeae were 2.7% and 0.4%, respectively. PCR had a resolved sensitivity and specificity of 100% and 99.8%, respectively, for C trachomatis, and 100% and 98.9%, respectively, for N gonorrhoeae. LCR was 100% sensitive and specific for both pathogens. The resolved sensitivity of the shell vial assay was 85%. No culture positive sample would have been missed by PCR or LCR. The inhibition rate for PCR was 4.8%. Conclusions-2-SP medium proved to be suitable for both PCR and LCR. It is not limited to any one test manufacturer and allows the performance of amplification techniques and viral and chlamydia culture from the same specimen. The LCR was more reliable than PCR on initial testing. However, hands on time is longer, and no amplification control is available for LCR. ( Clin Pathol 1997;50:947-950) 
Evaluation of 2-SP transport medium for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by two automated amplification systems and culture for chlamydia 0 Dubuis, M Gorgievski-Hrisoho, D Germann, L Matter Abstract Aims-To assess the performance of 2-sucrose-phosphate based transport medium (2-SP) for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae by an automated commercial polymerase chain reaction (PCR) and ligase chain reaction (LCR) compared to centrifugation culture on McCoy cells for C trachomatis. Second, to compare both amplification systems for initial diagnostic testing of a low prevalence population for sexually transmitted diseases. Methods-Four hundred and eighty one consecutive urogenital and conjunctival specimens were examined. All tests were performed on the same specimen collected with a dacron swab and transported in 2-SP medium. Samples that were positive by culture or by both PCR and LCR were considered to be true positives. Results-The prevalences of C trachomatis and of N gonorrhoeae were 2.7% and 0.4%, respectively. PCR had a resolved sensitivity and specificity of 100% and 99.8%, respectively, for C trachomatis, and 100% and 98.9%, respectively, for N gonorrhoeae. LCR was 100% sensitive and specific for both pathogens. The resolved sensitivity of the shell vial assay was 85%. In recent years, the introduction of polymerase chain reaction (PCR) and ligase chain reaction (LCR) based methods has resulted in a substantial increase in sensitivity and (compared with most other non-culture methods) specificity for the detection of C trachomatis and N gonorrhoeae in urogenital swab specimens and urine.8-6 The development of commercial, partially automated assays further simplified and shortened these procedures and made them available to a broader range of diagnostic laboratories.10 17 One Sof our concerns as a diagnostic laboratory was the increasing number of manufacturer and test specific specimen collection and transport systems, each one with its particular handling directions and variable compatibility with other assays. The same specimen collection and transport kit should be suitable for amplification techniques and for viral and chlamydial culture. In this study, we evaluated the performance of 2-sucrosephosphate (2-SP) based transport medium for the detection of C trachomatis and N gonorrhoeae in urogenital and ocular swab specimens with automated LCR and PCR techniques compared with culture for chlamydia. N gonorrhoeae culture was not an integral part of the study because (all from Merck, Darmstadt, Germany), 2.5 mg/l amphotericin B (Squibb, Baar, Switzerland), 100-120 mg/l gentamicin (Seromed, Berlin, Germany), 10 g/l bovine serum albumin (Sigma, Buchs, Switzerland), and 0.0025% phenol red solution (Flow Laboratories, Baar, Switzerland). AMPLIFICATION 
TECHNIQUES
Sample preparation and amplification/ detection were performed in distinct laboratory areas. Standard precautions to avoid crosscontamination were adopted.'8 LIGASE CHAIN REACTION LCR was performed with the LCx system (Abbott Laboratories, Delkenheim, Germany). Sample preparation followed a modified urine processing protocol. After vortexing briefly, 100 gl samples were transferred to a 1.5 ml conical microcentrifuge tube (Sarstedt, Sevelen, Switzerland) and centrifuged for 15 minutes at 9000 xg in a microcentrifuge. The supernatant was discarded and the pellet resuspended in 1 ml urine resuspension buffer from the kit. The microcentrifuge tube was heated at 97°C for 15 minutes in a heatblock and left for another 15 minutes to cool to room temperature. Aliquots of 100 p1 were transferred to "ready for use" unit dose tubes from the kit containing 100,l of mastermix with four oligonucleotide probes specific for the C trachomatis multicopy cryptic plasmid or the N gonorrhoeae Opa-1 gene, respectively. Further processing was performed according to the manufacturer's instructions.
POLYMERASE CHAIN REACTION
PCR was performed with the COBAS Amplicor system (Roche Molecular Diagnostic Systems, Basel, Switzerland). All steps of the sample preparation, amplification, and detection were performed according to the manufacturer's instructions. Briefly, 100 gl of 2-SP medium was added to 100 gl of lysis buffer from the kit. After 10 minutes of incubation at room temperature, 200 gl of specimen diluent from the kit was added, followed by another 10 minutes of incubation at room temperature. An aliquot of 50,l of the processed sample was transferred to the previously prepared amplification tubes, containing a mestermix with biotinylated primers for the cryptic plasmid of C trachomatis, the putative cytosine DNA methyltransferase gene of N gonorrhoeae, and the amplification control (DNA plasmid with primer binding regions identical to C trachomatis but unique probe binding region). A positive control for C trachomatis (a negative control for N gonorrhoeae) and for N gonorrhoeae (a negative control for C trachomatis) were run with each batch. The detection of the optional amplification control was applied to all samples. Amplification and detection are fully automated procedures with no intervening manipulations. Samples with a negative amplification control were retested after 1 0-fold dilution with the specimen diluent from the kit and 10 minutes heating in a heatblock at 950C. '9 CELL CULTURE Single pass cell culture was performed as a centrifugation culture (shell vial assay; SVA) on McCoy cell monolayers according to standard procedures.20 21 Briefly, 200 p1 sonicated sample was inoculated on to McCoy cell shell vials and centrifuged for 45 minutes at 700 xg at room temperature. The supernatant was discarded and Eagle's minimal essential medium supplemented with 10% inactivated fetal bovine serum and cycloheximide was added. The shell vials were incubated for 72 hours at 36°C in an atmosphere with 5% CO2. After incubation they were fixed with 4°C cold acetone/ methanol and stained with chlamydia genus specific monoclonal antibodies (Argene, Varilhes, France) and fluorescein labelled monoclonal antimouse F(ab')2 fragments (BioScience, Emmenbriicke, Switzerland). The number of inclusions was counted on a fluorescence microscope with a mercury 100 lamp at a magnification of x200. One or more typical inclusions were considered to be positive.
RESOLUTION OF DISCREPANT SAMPLES
Samples positive by either culture alone or with both amplification techniques were considered to be true positives. Samples positive or equivocal by just one amplification technique were considered discrepant. For C trachomatis, all discrepant results could be resolved by repeating LCR and PCR from new aliquots, whereas for N gonorrhoeae most discrepant results could be resolved this way. One repeatedly discrepant specimen for Ngonorrhoeae was tested by a confirmatory PCR (16S rRNA; Roche, Basel, Switzerland).
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Results
Of the 410 cervical and 49 urethral specimens, 11 (2.7%) and two (4.1%), respectively, were positive for C trachomatis by LCR and PCR. Ten (91 %) and one, respectively, of these positive specimens were also positive by SVA. Both positive urethral specimens were from men with urethritis. One cervical swab was initially equivocal by PCR with a negative amplification control but positive by both LCR and SVA. This sample turned out to be PCR positive on retesting after eliminating inhibitors with pretreatment (10-fold dilution and heating for 10 minutes at 95°C). One culture and LCR negative sample was not reproducibly positive for C trachomatis by PCR and, therefore, was considered to be a false positive (table 1) . One cervical and one male urethral specimen were positive for N gonorrhoeae by both amplification techniques. The cervical specimen was initially negative by PCR with a negative amplification control and turned out to be positive on retesting, after elimination of inhibitors with the sample pretreatment described above. Four cervical samples were positive initially for Ngonorrhoeae by PCR only and negative on retesting. Three additional LCR negative samples were equivocal by PCR, one of them reproducibly. This sample was negative by the backup PCR of the manufacturer and, therefore, it was considered negative in our evaluation (table 2). As mentioned earlier, N gonorrhoeae culture was not an integral part of this study. Nevertheless, Ngonorrhoeae culture on supplemented GC medium (Difco Laboratories, Detroit, Michigan, USA) in a 5% CO2 atmosphere at 35°C could be performed with specimens collected at the same examination for 361 patients, and in particular, for all patients with positive or equivocal initial amplification results. Of the two confirmed positive samples the urethral swab was culture positive and the cervical specimen negative. None of the negative, equivocal, and initially discrepant samples was positive by culture. Despite the expectancy of dual infections no specimen was positive for both pathogens.2
Due to the lack of a built in amplification control, no data concerning inhibition with the LCR assay were available. The overall inhibition rate of the PCR assay assessed with the amplification control of the COBAS Amplicor was 4.8%. The individual inhibition rates for cervical, urethral, and conjunctival swabs were 5.1%, 6.1%, and 0.0%, respectively.
PCR had a resolved sensitivity, specificity, and positive predictive value of 100%, 99.8%, and 92.9% for C trachomatis, and 100%, 98.9%, and 33.3% for N gonorrhoeae, respectively. The LCR was 100% sensitive and specific for both pathogens. For N gonorrhoeae, only the 361 patients with available culture results were taken into consideration. The resolved sensitivity of the SVA was 85%.
Discussion
LCx and COBAS Amplicor are partially automated devices. For both assays the complete performance time varies between four and five hours, depending on the number of samples tested. As the COBAS Amplicor is a multiplex PCR and automation is more advanced, hands on time is shorter and the daily maximum possible sample through put for a skilled technician is higher than for the LCx (96 v 48 samples).
The performance of 2-SP with the Amplicor PCR has already been assessed, and the use of 2-SP as a transport medium is approved by the manufacturer.'9 22 For the LCx system very few data concerning this subject are available.22 We demonstrated that 2-SP was also suitable for LCR. The only disadvantage of 2-SP is that it has to be stored at 4-8°C. The shelf life of 2-SP kept at room temperature should, therefore, be evaluated for amplification techniques.
As a historical comparison, the prevalence of 2.7% for C trachomatis and 0.4% for N gonorrhoeae is similar to the prevalence we experienced before in a similar population (3.1% for C trachomatis, 0.6% for N gonorrhoeae) with 755 samples collected in Roche Amplicor transport medium (334 tested with COBAS Amplicor, 421 tested with the manual Amplicor method).
The overall inhibition rate of 4.8% with COBAS Amplicor was clearly below the rate previously experienced by us (-18%) and described by others with the Amplicor transport medium. ' 
